Showing results (1761-1770 of 1,881) with videos related to

Sort By:
Pageof 189
Immunotherapy|August 10, 2022
Sutimlimab for treatment of cold agglutinin disease: why, how and for whom?Sigbjørn Berentsen, Wilma Barcellini, Shirley D'Sa, et al.
Immunotherapy|August 25, 2022
Therapeutic intervention of glioma with the novel antineoplastic agent T11TS: the story so farSuhnrita Chaudhuri, Sagar Acharya, Swapna Chaudhuri
Immunotherapy|February 7, 2023
Sintilimab plus chemotherapy for first-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer: network meta-analysisCliff Molife, Alan Brnabic, Victoria J Stefaniak, et al.
Immunotherapy|May 6, 2021
Therapeutic cancer vaccine therapy for acute myeloid leukemiaMing Wu, Sheng Wang, Jian-Yu Chen, et al.
Immunotherapy|May 6, 2021
GO-BEYOND: a real-world study of persistence of golimumab in patients with axial spondyloarthritis and rheumatoid arthritis in TurkeyServet Akar, Umut Kalyoncu, Ediz Dalkilic, et al.
Immunotherapy|May 6, 2021
Mesenchymal stem cells derived from human dental follicle modulate the aberrant immune response in atopic dermatitisNoushin Zibandeh, Deniz Genc, Zuleyha Ozgen, et al.
Immunotherapy|June 26, 2020
Investigative therapy for advanced esophageal cancer using the option for combined immunotherapy and chemotherapyHuan Wang, Tian-Tian Xuan, Ying Chen, et al.
Immunotherapy|August 9, 2021
Anti-PD-1 and regorafenib induce severe multisystem adverse events in microsatellite stability metastatic colorectal cancer: a case reportYuchen Yang, Lingyan Xu, Danping Wang, et al.
Immunotherapy|September 9, 2021
Combination of bevacizumab and dual immunotherapy for extensive-disease small-cell lung cancer: a case reportLei Song, Rengui Zhou, Xiangyong Li, et al.
Immunotherapy|September 9, 2021
Immunotherapy in hematological malignancies: recent advances and open questionsEssam A Tawfik, Norah A Aldrak, Shahad H Albrahim, et al.
Pageof 189